1,25-dihydroxyvitamin D3 production by human keratinocytes: kinetics and regulation

Human foreskin keratinocytes in vitro metabolize 25-hydroxyvitamin D3 to a number of metabolites, including 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). This metabolite remains mostly within the cell and does not accumulate in the medium under the conditions of these experiments. With time, 1,25(OH)2D3 i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 1986-08, Vol.78 (2), p.557-566
Hauptverfasser: BIKLE, D. D, NEMANIC, M. K, GEE, E, ELIAS, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 566
container_issue 2
container_start_page 557
container_title The Journal of clinical investigation
container_volume 78
creator BIKLE, D. D
NEMANIC, M. K
GEE, E
ELIAS, P
description Human foreskin keratinocytes in vitro metabolize 25-hydroxyvitamin D3 to a number of metabolites, including 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). This metabolite remains mostly within the cell and does not accumulate in the medium under the conditions of these experiments. With time, 1,25(OH)2D3 is catabolized, and more polar metabolites appear in both the cells and the medium. The production of 1,25(OH)2D3 has an apparent Michaelis constant (Km) for 25-hydroxyvitamin D3 of 5.4 X 10(-8) M. The levels of 1,25(OH)2D3 within the cell are increased both by increased production and decreased catabolism when parathyroid hormone(1-34) and isobutylmethylxanthine are added. Exogenously added 1,25(OH)2D3 at concentrations as low as 10(-12) M reduces endogenous 1,25(OH)2D3 production, increases 1,25(OH)2D3 catabolism, and increases 24,25-dihydroxyvitamin D3 production by an actinomycin D-sensitive process. These data indicate that the regulation of 1,25(OH)2D3 production by keratinocytes is similar to, but not identical to the regulation of 1,25(OH)2D3 by the kidney.
doi_str_mv 10.1172/jci112609
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_423594</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76957576</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-36a78d5082dab9c6041b56ef48e9cb1fff8eaa574841795d11b19c9496f7ec5e3</originalsourceid><addsrcrecordid>eNpVkU9v1DAQxS1EVZbCgQ-AlANCQiLF4_gvEge0QFtUiQNwtiaO03Wb2Fs7qci3Z6tdreA0h_d7M6P3CHkF9BxAsQ-3LgAwSc0TsgIhdK1Zo5-SFaUMaqMa_Yw8L-WWUuBc8FNyyjiTDdUr8hPeM1F3YbN0Of1ZHsKEY4jVl6ba5tTNbgopVu1SbeYRY3XnM04hJrdMvnys7kL0U3ClwthV2d_MAz7yL8hJj0PxLw_zjPz-9vXX-rK-_nFxtf58XTsu-VQ3EpXuBNWsw9Y4STm0Qvqea29cC33fa48oFNcclBEdQAvGGW5kr7wTvjkjn_Z7t3M7-s75OGUc7DaHEfNiEwb7vxLDxt6kB8tZIwzf-d8e_Dndz75MdgzF-WHA6NNcrJJGKKHkDny3B11OpWTfH28AtY8F2O_rq30BO_b1v08dyUPiO_3NQcficOgzRhfKEdNgQAFt_gInko8N</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76957576</pqid></control><display><type>article</type><title>1,25-dihydroxyvitamin D3 production by human keratinocytes: kinetics and regulation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>BIKLE, D. D ; NEMANIC, M. K ; GEE, E ; ELIAS, P</creator><creatorcontrib>BIKLE, D. D ; NEMANIC, M. K ; GEE, E ; ELIAS, P</creatorcontrib><description>Human foreskin keratinocytes in vitro metabolize 25-hydroxyvitamin D3 to a number of metabolites, including 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). This metabolite remains mostly within the cell and does not accumulate in the medium under the conditions of these experiments. With time, 1,25(OH)2D3 is catabolized, and more polar metabolites appear in both the cells and the medium. The production of 1,25(OH)2D3 has an apparent Michaelis constant (Km) for 25-hydroxyvitamin D3 of 5.4 X 10(-8) M. The levels of 1,25(OH)2D3 within the cell are increased both by increased production and decreased catabolism when parathyroid hormone(1-34) and isobutylmethylxanthine are added. Exogenously added 1,25(OH)2D3 at concentrations as low as 10(-12) M reduces endogenous 1,25(OH)2D3 production, increases 1,25(OH)2D3 catabolism, and increases 24,25-dihydroxyvitamin D3 production by an actinomycin D-sensitive process. These data indicate that the regulation of 1,25(OH)2D3 production by keratinocytes is similar to, but not identical to the regulation of 1,25(OH)2D3 by the kidney.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/jci112609</identifier><identifier>PMID: 2426308</identifier><identifier>CODEN: JCINAO</identifier><language>eng</language><publisher>Ann Arbor, MI: American Society for Clinical Investigation</publisher><subject>1-Methyl-3-isobutylxanthine - pharmacology ; Biological and medical sciences ; Calcitriol - biosynthesis ; Calcitriol - metabolism ; Calcium - pharmacology ; Cells, Cultured ; Culture Media ; Fundamental and applied biological sciences. Psychology ; Humans ; Keratins ; Kinetics ; Parathyroid Hormone - pharmacology ; Skin - cytology ; Skin - drug effects ; Skin - metabolism ; Substrate Specificity ; Vertebrates: skin, associated glands, phaneres, light organs, various exocrine glands (salt gland, uropygial gland...), adipose tissue, connective tissue</subject><ispartof>The Journal of clinical investigation, 1986-08, Vol.78 (2), p.557-566</ispartof><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-36a78d5082dab9c6041b56ef48e9cb1fff8eaa574841795d11b19c9496f7ec5e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC423594/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC423594/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8191710$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2426308$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BIKLE, D. D</creatorcontrib><creatorcontrib>NEMANIC, M. K</creatorcontrib><creatorcontrib>GEE, E</creatorcontrib><creatorcontrib>ELIAS, P</creatorcontrib><title>1,25-dihydroxyvitamin D3 production by human keratinocytes: kinetics and regulation</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>Human foreskin keratinocytes in vitro metabolize 25-hydroxyvitamin D3 to a number of metabolites, including 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). This metabolite remains mostly within the cell and does not accumulate in the medium under the conditions of these experiments. With time, 1,25(OH)2D3 is catabolized, and more polar metabolites appear in both the cells and the medium. The production of 1,25(OH)2D3 has an apparent Michaelis constant (Km) for 25-hydroxyvitamin D3 of 5.4 X 10(-8) M. The levels of 1,25(OH)2D3 within the cell are increased both by increased production and decreased catabolism when parathyroid hormone(1-34) and isobutylmethylxanthine are added. Exogenously added 1,25(OH)2D3 at concentrations as low as 10(-12) M reduces endogenous 1,25(OH)2D3 production, increases 1,25(OH)2D3 catabolism, and increases 24,25-dihydroxyvitamin D3 production by an actinomycin D-sensitive process. These data indicate that the regulation of 1,25(OH)2D3 production by keratinocytes is similar to, but not identical to the regulation of 1,25(OH)2D3 by the kidney.</description><subject>1-Methyl-3-isobutylxanthine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Calcitriol - biosynthesis</subject><subject>Calcitriol - metabolism</subject><subject>Calcium - pharmacology</subject><subject>Cells, Cultured</subject><subject>Culture Media</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Keratins</subject><subject>Kinetics</subject><subject>Parathyroid Hormone - pharmacology</subject><subject>Skin - cytology</subject><subject>Skin - drug effects</subject><subject>Skin - metabolism</subject><subject>Substrate Specificity</subject><subject>Vertebrates: skin, associated glands, phaneres, light organs, various exocrine glands (salt gland, uropygial gland...), adipose tissue, connective tissue</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU9v1DAQxS1EVZbCgQ-AlANCQiLF4_gvEge0QFtUiQNwtiaO03Wb2Fs7qci3Z6tdreA0h_d7M6P3CHkF9BxAsQ-3LgAwSc0TsgIhdK1Zo5-SFaUMaqMa_Yw8L-WWUuBc8FNyyjiTDdUr8hPeM1F3YbN0Of1ZHsKEY4jVl6ba5tTNbgopVu1SbeYRY3XnM04hJrdMvnys7kL0U3ClwthV2d_MAz7yL8hJj0PxLw_zjPz-9vXX-rK-_nFxtf58XTsu-VQ3EpXuBNWsw9Y4STm0Qvqea29cC33fa48oFNcclBEdQAvGGW5kr7wTvjkjn_Z7t3M7-s75OGUc7DaHEfNiEwb7vxLDxt6kB8tZIwzf-d8e_Dndz75MdgzF-WHA6NNcrJJGKKHkDny3B11OpWTfH28AtY8F2O_rq30BO_b1v08dyUPiO_3NQcficOgzRhfKEdNgQAFt_gInko8N</recordid><startdate>19860801</startdate><enddate>19860801</enddate><creator>BIKLE, D. D</creator><creator>NEMANIC, M. K</creator><creator>GEE, E</creator><creator>ELIAS, P</creator><general>American Society for Clinical Investigation</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19860801</creationdate><title>1,25-dihydroxyvitamin D3 production by human keratinocytes: kinetics and regulation</title><author>BIKLE, D. D ; NEMANIC, M. K ; GEE, E ; ELIAS, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-36a78d5082dab9c6041b56ef48e9cb1fff8eaa574841795d11b19c9496f7ec5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>1-Methyl-3-isobutylxanthine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Calcitriol - biosynthesis</topic><topic>Calcitriol - metabolism</topic><topic>Calcium - pharmacology</topic><topic>Cells, Cultured</topic><topic>Culture Media</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Keratins</topic><topic>Kinetics</topic><topic>Parathyroid Hormone - pharmacology</topic><topic>Skin - cytology</topic><topic>Skin - drug effects</topic><topic>Skin - metabolism</topic><topic>Substrate Specificity</topic><topic>Vertebrates: skin, associated glands, phaneres, light organs, various exocrine glands (salt gland, uropygial gland...), adipose tissue, connective tissue</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BIKLE, D. D</creatorcontrib><creatorcontrib>NEMANIC, M. K</creatorcontrib><creatorcontrib>GEE, E</creatorcontrib><creatorcontrib>ELIAS, P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BIKLE, D. D</au><au>NEMANIC, M. K</au><au>GEE, E</au><au>ELIAS, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>1,25-dihydroxyvitamin D3 production by human keratinocytes: kinetics and regulation</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>1986-08-01</date><risdate>1986</risdate><volume>78</volume><issue>2</issue><spage>557</spage><epage>566</epage><pages>557-566</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><coden>JCINAO</coden><abstract>Human foreskin keratinocytes in vitro metabolize 25-hydroxyvitamin D3 to a number of metabolites, including 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). This metabolite remains mostly within the cell and does not accumulate in the medium under the conditions of these experiments. With time, 1,25(OH)2D3 is catabolized, and more polar metabolites appear in both the cells and the medium. The production of 1,25(OH)2D3 has an apparent Michaelis constant (Km) for 25-hydroxyvitamin D3 of 5.4 X 10(-8) M. The levels of 1,25(OH)2D3 within the cell are increased both by increased production and decreased catabolism when parathyroid hormone(1-34) and isobutylmethylxanthine are added. Exogenously added 1,25(OH)2D3 at concentrations as low as 10(-12) M reduces endogenous 1,25(OH)2D3 production, increases 1,25(OH)2D3 catabolism, and increases 24,25-dihydroxyvitamin D3 production by an actinomycin D-sensitive process. These data indicate that the regulation of 1,25(OH)2D3 production by keratinocytes is similar to, but not identical to the regulation of 1,25(OH)2D3 by the kidney.</abstract><cop>Ann Arbor, MI</cop><pub>American Society for Clinical Investigation</pub><pmid>2426308</pmid><doi>10.1172/jci112609</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9738
ispartof The Journal of clinical investigation, 1986-08, Vol.78 (2), p.557-566
issn 0021-9738
1558-8238
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_423594
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects 1-Methyl-3-isobutylxanthine - pharmacology
Biological and medical sciences
Calcitriol - biosynthesis
Calcitriol - metabolism
Calcium - pharmacology
Cells, Cultured
Culture Media
Fundamental and applied biological sciences. Psychology
Humans
Keratins
Kinetics
Parathyroid Hormone - pharmacology
Skin - cytology
Skin - drug effects
Skin - metabolism
Substrate Specificity
Vertebrates: skin, associated glands, phaneres, light organs, various exocrine glands (salt gland, uropygial gland...), adipose tissue, connective tissue
title 1,25-dihydroxyvitamin D3 production by human keratinocytes: kinetics and regulation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T10%3A38%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=1,25-dihydroxyvitamin%20D3%20production%20by%20human%20keratinocytes:%20kinetics%20and%20regulation&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=BIKLE,%20D.%20D&rft.date=1986-08-01&rft.volume=78&rft.issue=2&rft.spage=557&rft.epage=566&rft.pages=557-566&rft.issn=0021-9738&rft.eissn=1558-8238&rft.coden=JCINAO&rft_id=info:doi/10.1172/jci112609&rft_dat=%3Cproquest_pubme%3E76957576%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76957576&rft_id=info:pmid/2426308&rfr_iscdi=true